Viewing Study NCT00042393


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2026-01-02 @ 6:44 AM
Study NCT ID: NCT00042393
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2014-01-07
First Post: 2002-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module References Module